Institutt for farmasi
Engelsk personkortNaderkhani, Elenaz
Stipendiat
Farmasi
Funksjon
PhD student
Telefon
776 45239
Epost
Kontor/besøksadresse
Farmasi
FARM F3.235
Forskningsinteresser
Permeabilitet over biologiske barrierer
Phospholipid vesicle-based permeation assay (PVPA)
Liposomer som legemiddelbærer
Forskningsprosjekter
Oral absorption of new drug compounds:further development and optimization of the phospholipid vesicle-based permeation assay (PVPA)
Publikasjonsliste
Masteravhandling
Investigation and optimization of liposome formulation for use as drug carrier for the anticancer agent Camptothecin (June 2011)
Andre publikasjoner
Whitaker, RD; Ingebrigsten, SG; Naderkhani, E; Skar, ML; Flaten, GE (2013) Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin, Journal of Liposome Research
Publikasjoner i Munin
Arbeider i CRIStin
- Naderkhani, Elenaz; Skalko-Basnet, Natasa; Flaten, Gøril Eide. Improved prediction of intestinal permeability using the phospholipid vesicle-based permeation assay. 9th Central European Symposium on Pharmaceutical Technology 2012-09-20 - 2012-09-22 2012.
- Naderkhani, Elenaz; Engesland, André; Ryzhakov, Alexey; Flaten, Gøril Eide. The phospholipid vesicle-based permeation assay (PVPA) for screening of drug permeability. CRS Nordic 2012-06-03 - 2012.
